Cargando…
The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β
Transforming growth factor-β (TGF-β) plays a critical role in regulating cell growth and differentiation. Epithelial to mesenchymal transition (EMT) induced by TGF-β promotes cancer cell migration, invasion, and proliferation. Pirfenidone (5-methyl-1-phenyl-2(1 H)-pyridone, PFD), an approved drug fo...
Autores principales: | Wang, Gang, Zhou, Xiaowan, Guo, Zengli, Huang, Nan, Li, Juan, Lv, Yanfang, Han, Lulu, Zheng, Wei, Xu, Dandan, Chai, Dafei, Li, Huizhong, Li, Liantao, Zheng, Junnian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824226/ https://www.ncbi.nlm.nih.gov/pubmed/35130111 http://dx.doi.org/10.1080/15384047.2022.2035629 |
Ejemplares similares
-
The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018) -
Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery
por: Chen, Yuxin, et al.
Publicado: (2022) -
Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
por: Zhang, Qing, et al.
Publicado: (2017) -
Manipulation of Mitochondrial Plasticity Changes the Metabolic Competition Between “Foe” and “Friend” During Tumor Malignant Transformation
por: Tian, Hui, et al.
Publicado: (2020) -
Pirfenidone normalizes the tumor microenvironment to improve chemotherapy
por: Polydorou, Christiana, et al.
Publicado: (2017)